Literature DB >> 26125413

Apolipoprotein A-I mimetic peptide reverses impaired arterial healing after injury by reducing oxidative stress.

Michael A Rosenbaum1, Pinaki Chaudhuri2, Benjamin Abelson2, Brandy N Cross3, Linda M Graham4.   

Abstract

OBJECTIVE: Endothelial cell (EC) migration is essential for healing of arterial injuries caused by angioplasty, but a high cholesterol diet inhibits endothelial repair. In vivo studies suggest that apolipoprotein A-I (apoA-I), the major protein constituent of HDL, is essential for normal healing of arterial injuries. ApoA-I mimetics, including 4F, have been designed to mimic the amphipathic portion of the apoA-I molecule. This study was undertaken to determine if 4F improves endothelial migration and healing.
METHODS: A razor scrape assay was used to analyze the effect of 4F on EC migration in vitro. Endothelial healing in vivo was assessed following electrical injury of carotid arteries in mice. Markers of oxidative stress were also examined.
RESULTS: Lipid oxidation products inhibited EC migration in vitro, but preincubation with L-4F preserved EC migration. Endothelial healing of carotid arterial injuries in mice on a high cholesterol diet was delayed compared with mice on a chow diet with 27.8% vs. 48.2% healing, respectively, at 5 days. Administration of D-4F improved endothelial healing in mice on a high cholesterol diet to 43.4%. D-4F administration had no effect on lipid levels but decreased markers of oxidation. In vivo, there was a significant inverse correlation between endothelial healing and plasma markers of oxidative stress.
CONCLUSION: These studies suggested that an apoA-I mimetic can improve endothelial healing of arterial injuries by decreasing oxidative stress. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Apolipoprotein A-I mimetic; Arterial healing; D-4F; Endothelial migration; Endothelium; Hypercholesterolemia; L-4F

Mesh:

Substances:

Year:  2015        PMID: 26125413      PMCID: PMC4529116          DOI: 10.1016/j.atherosclerosis.2015.06.018

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  37 in total

Review 1.  Antiinflammatory properties of HDL.

Authors:  Philip J Barter; Stephen Nicholls; Kerry-Anne Rye; G M Anantharamaiah; Mohamad Navab; Alan M Fogelman
Journal:  Circ Res       Date:  2004-10-15       Impact factor: 17.367

2.  Endothelial regeneration. II. Restitution of endothelial continuity.

Authors:  C C Haudenschild; S M Schwartz
Journal:  Lab Invest       Date:  1979-11       Impact factor: 5.662

3.  Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity.

Authors:  Geeta Datta; Raquel F Epand; Richard M Epand; Manjula Chaddha; Matthew A Kirksey; David W Garber; Sissel Lund-Katz; Michael C Phillips; Susan Hama; Mohamad Navab; Alan M Fogelman; Mayakonda N Palgunachari; Jere P Segrest; G M Anantharamaiah
Journal:  J Biol Chem       Date:  2004-04-08       Impact factor: 5.157

4.  Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.

Authors:  Mohamad Navab; G M Anantharamaiah; Srinivasa T Reddy; Susan Hama; Greg Hough; Victor R Grijalva; Alan C Wagner; Joy S Frank; Geeta Datta; David Garber; Alan M Fogelman
Journal:  Circulation       Date:  2004-06-14       Impact factor: 29.690

5.  High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors.

Authors:  Takao Kimura; Koichi Sato; Enkhzol Malchinkhuu; Hideaki Tomura; Kenichi Tamama; Atsushi Kuwabara; Masami Murakami; Fumikazu Okajima
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-29       Impact factor: 8.311

6.  Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits.

Authors:  S Ameli; A Hultgardh-Nilsson; B Cercek; P K Shah; J S Forrester; H Ageland; J Nilsson
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

7.  Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

Authors:  E M Rubin; R M Krauss; E A Spangler; J G Verstuyft; S M Clift
Journal:  Nature       Date:  1991-09-19       Impact factor: 49.962

8.  Alpha-tocopherol preserves endothelial cell migration in the presence of cell-oxidized low-density lipoprotein by inhibiting changes in cell membrane fluidity.

Authors:  John A van Aalst; William Burmeister; Paul L Fox; Linda M Graham
Journal:  J Vasc Surg       Date:  2004-01       Impact factor: 4.268

9.  Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo.

Authors:  YuZhen Zhang; Ilaria Zanotti; Muredach P Reilly; Jane M Glick; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

10.  Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro.

Authors:  G Murugesan; G M Chisolm; P L Fox
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

View more
  12 in total

1.  Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux.

Authors:  David Meriwether; Dawoud Sulaiman; Alan Wagner; Victor Grijalva; Izumi Kaji; Kevin J Williams; Liqing Yu; Spencer Fogelman; Carmen Volpe; Steven J Bensinger; G M Anantharamaiah; Ishaiahu Shechter; Alan M Fogelman; Srinivasa T Reddy
Journal:  J Lipid Res       Date:  2016-05-19       Impact factor: 5.922

2.  Integration of TRPC6 and NADPH oxidase activation in lysophosphatidylcholine-induced TRPC5 externalization.

Authors:  Pinaki Chaudhuri; Michael A Rosenbaum; Lutz Birnbaumer; Linda M Graham
Journal:  Am J Physiol Cell Physiol       Date:  2017-08-23       Impact factor: 4.249

Review 3.  Apolipoprotein-AI and AIBP synergetic anti-inflammation as vascular diseases therapy: the new perspective.

Authors:  Ampadu O Jackson; Ganiyu A Rahman; Shiyin Long
Journal:  Mol Cell Biochem       Date:  2021-04-03       Impact factor: 3.396

4.  HDL Mimetic Peptides.

Authors:  Jie Chen; Jiewen Liu; Baoqi Yu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr192 and compromises its cardioprotective activity.

Authors:  Ilona Kareinen; Marc Baumann; Su Duy Nguyen; Katariina Maaninka; Andrey Anisimov; Minoru Tozuka; Matti Jauhiainen; Miriam Lee-Rueckert; Petri T Kovanen
Journal:  J Lipid Res       Date:  2018-03-26       Impact factor: 5.922

Review 6.  The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease.

Authors:  Carlota Recio; Francesco Maione; Asif J Iqbal; Nicola Mascolo; Vincenzo De Feo
Journal:  Front Pharmacol       Date:  2017-01-06       Impact factor: 5.810

7.  Commentary: The apolipoprotein A-I mimetic peptide, D-4F, restrains neointimal formation through heme oxygenase-1 up-regulation.

Authors:  Giovanni Li Volti; Roberto Avola; Daniele Tibullo
Journal:  Front Pharmacol       Date:  2017-09-29       Impact factor: 5.810

8.  Lipoprotein modulation of proteinuric renal injury.

Authors:  Yohei Tsuchida; Jianyong Zhong; Tadashi Otsuka; Anna Dikalova; Ira Pastan; G M Anantharamaiah; MacRae F Linton; Patricia G Yancey; T Alp Ikizler; Agnes B Fogo; Haichun Yang; Valentina Kon
Journal:  Lab Invest       Date:  2019-04-24       Impact factor: 5.662

9.  Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals.

Authors:  Montserrat Baldan-Martin; Juan A Lopez; Nerea Corbacho-Alonso; Paula J Martinez; Elena Rodriguez-Sanchez; Laura Mourino-Alvarez; Tamara Sastre-Oliva; Tatiana Martin-Rojas; Raul Rincón; Eva Calvo; Jesus Vazquez; Fernando Vivanco; Luis R Padial; Gloria Alvarez-Llamas; Gema Ruiz-Hurtado; Luis M Ruilope; Maria G Barderas
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

10.  An ApoA-I Mimic Peptide of 4F Promotes SDF-1α Expression in Endothelial Cells Through PI3K/Akt/ERK/HIF-1α Signaling Pathway.

Authors:  Kaixuan Lv; Lingyu Kong; Mei Yang; Linlin Zhang; Shangmin Chu; Lichun Zhang; Jielun Yu; Guoshen Zhong; Yanhua Shi; Xia Wang; Nana Yang
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.